CJC NO DAC

CJC-1295 (No DAC) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to interact with growth hormone-releasing hormone receptors in the anterior pituitary. Unlike the DAC-modified version, CJC-1295 (No DAC) does not contain a Drug Affinity Complex (DAC), resulting in a shorter circulating half-life and pharmacokinetic profile. It has been the subject of scientific investigation examining its receptor binding characteristics, endocrine signaling, pulsatile growth hormone release dynamics, pharmacokinetics, and overall mechanism of action. Ongoing laboratory and clinical research continues to evaluate its biological properties and physiological interactions under controlled study conditions.